Reproductive rights advocates are on edge over a lawsuit to revoke the decades-old Food and Drug Administration (FDA) approval of mifepristone, which, if successful, would end legal access to ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. During the first Trump administration, South Asia, particularly India, fared ...